The PE Ratio as of December 2025 (TTM) for BioDlink International Company Limited (1875.HK) is 100.50

According to BioDlink International Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is 100.50. This represents a change of 133.04% compared to the average of 43.13 of the last 4 quarters.

BioDlink International Company Limited (1875.HK) Historical PE Ratio (quarterly & annually)

How has 1875.HK PE Ratio performed in the past?

The mean historical PE Ratio of BioDlink International Company Limited over the last ten years is -10.06. The current 100.50 PE Ratio has changed -100039.04% with respect to the historical average. Over the past ten years (40 quarters), 1875.HK's PE Ratio was at its highest in in the December 2024 quarter at 95.33. The PE Ratio was at its lowest in in the June 2022 quarter at -24.82.

BioDlink International Company Limited (1875.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioDlink International Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioDlink International Company Limited (1875.HK) Average PE Ratio

How has 1875.HK PE Ratio performed in the past?

The current PE Ratio of BioDlink International Company Limited (1875.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioDlink International Company Limited (1875.HK) PE Ratio vs. Peers

How is 1875.HK’s PE Ratio compared to its peers?

BioDlink International Company Limited’s PE Ratio is greater than 3D Medicines Inc. (-5.82), greater than Genor Biopharma Holdings Limited (77.41), greater than Brii Biosciences Limited (-2.61), greater than Wuhan YZY Biopharma Co Ltd (-15.92), greater than JW (Cayman) Therapeutics Co. Ltd (-1.58), greater than Transcenta Holding Limited (-3.04), greater than Immunotech Biopharm Ltd (-5.83), greater than Zhaoke Ophthalmology Limited (-5.09), greater than Sunho Biologics, Inc. (-11.14), greater than Gaush Meditech Ltd (11.52),

Build a custom stock screener for BioDlink International Company Limited (1875.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioDlink International Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioDlink International Company Limited (1875.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioDlink International Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.